Validation of the Diabetomics CovAB SARS-CoV-2 antibody test in children: comparison with serology.

ABSTRACT: Monitoring antibody prevalence is a valuable tool to evaluate the burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a community, identify risk factors, and assess the impact of clinical and public health intervention strategies. The antibody prevalence of SARS-CoV-2 in children in the United States in early 2022 was estimated by the Centers for Disease Control and Prevention to be 74.2%, using seroprevalence from a variety of sources. A study by the New Jersey Department of Health in late 2022/early 2023 in unvaccinated children found a lower prevalence, 68% when using a gum swab method to detect antibodies. This study compared the accuracy of the gum swab method to detect antibodies with simultaneously obtained serological samples in additional children. This cross

SUBMITTER: Gurumurthy M 

PROVIDER: S-EPMC11537009 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature